Please select the option that best describes you:
Topics:
Rheumatology • Sjogren’s syndrome
What biomarkers or patient characteristics do you feel best predict response to B cell depleting therapies in a patient with Sjogren's?
Answer from: at Community Practice
At this point, I do not think there is a consensus about clinically available biomarkers that reliably predict response rate to B-cell-depleting therapies in SjD. There are some research studies pointing to changes in flow cytometry, immunohistopathology, and cytokine production, but these research ...
Sign in or Register to read more
Answer from: at Community Practice
At present, it may depend on the Sjogren's phenotype being treated with B-cell depleting therapies. If it is vasculitis with or without cryo, cryoglobulins, rheumatoid factor, and complements are helpful, along with inflammatory markers (ESR/CRP). I also note the level of total IgG, if elevated, may...